查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1824451

2025年放射治療全球市場報告

Radiotheranostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年放射治療市場將快速成長，到2029年將達到168.7億美元，年複合成長率(CAGR)為13.8%。預測期內的成長歸因於標靶癌症治療的進步、腫瘤學研究的拓展、慢性病的增加以及治療診斷應用的不斷成長。預測期內的主要趨勢包括治療診斷放射性藥物的發展、腫瘤學以外的應用擴展、個人化放射性藥物、放射治療中的奈米技術、監管變革以及標準化。

未來五年13.8%的成長預測比我們先前的預測略有下降，下降了0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。徵收關稅可能會擾亂美國供應鏈，增加從荷蘭和韓國進口的氟脫氧葡萄糖-正子斷層掃描放射性示蹤劑和熱凝探針的成本，從而可能限制標靶治療，並增加診斷成像的負擔。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，其影響可能會更加廣泛。

預計癌症發生率的上升將在未來推動放射治療市場的成長。癌症的特徵是體內某些細胞不受控制地發展並轉移到其他部位。放射治療藥物廣泛應用於腫瘤學，透過配對診斷和治療放射性核種探針，提供了個人化醫療的概念。這些探針能夠根據患者的具體情況選擇性地、有針對性地檢測和治療特定細胞（通常是癌細胞），從而提高治療效果並改善臨床結果。例如，2024 年 1 月，專注於癌症宣傳的美國非營利組織美國癌症協會報告稱，美國癌症患者人數從 2023 年的 1,958,310 人增加到 2,011,140 人，成長了 2.19%。因此，癌症發生率的上升正在推動放射治療市場的發展。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球放射熱學：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球放射熱療市場：成長率分析
  • 全球放射治療市場表現：規模與成長，2019-2024
  • 全球放射治療市場預測：2024-2029 年及 2034 年規模與成長
  • 全球放射治療學：總目標市場（TAM）

第6章 市場細分

  • 全球放射熱療市場：依放射性同位素、實際與預測，2019-2024 年、2024-2029 年、2034 年
  • Technetium-99
  • 鎵-68
  • 碘-131
  • 碘-123
  • 氟脫氧葡萄糖-18F
  • 釔90
  • 鎦（Lu）177
  • 銅（Cu）67
  • 銅（Cu）64
  • 其他放射性同位素
  • 全球放射熱療市場：依方法、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 標靶治療
  • 針對性的診斷
  • 全球放射熱成像市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 腫瘤學
  • 非腫瘤學
  • 全球放射熱療市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 製藥和生物技術公司
  • 其他最終用戶
  • 全球放射性熱療市場：Technetium-99細分市場（依放射性同位素分類），2019-2024年、2024-2029、2034年
  • Technetium-99m
  • Technetium-99Technetium
  • 全球放射熱成像市場：鎵-68 細分（依放射性同位素）、實際及預測（2019-2024 年、2024-2029 年、2034 年）
  • 鎵-68碘酸鹽
  • 鎵-68 PSMA
  • 全球放射熱療市場：碘-131細分市場（按放射性同位素），2019-2024年、2024-2029年、2034年
  • 碘-131在甲狀腺癌治療的應用
  • 碘-131治療甲狀腺亢進
  • 全球放射熱療市場：碘-123 細分市場（依放射性同位素分類）、實際及預測（2019-2024 年、2024-2029 年、2034 年）
  • 碘-123用於甲狀腺掃描
  • 碘-123用於心臟影像影像
  • 全球放射熱療市場：氟脫氧葡萄糖-18F (FDG) 細分市場（按放射性同位素分類），實際及預測，2019-2024 年、2024-2029 年、2034 年
  • FDG用於腫瘤成像
  • FDG用於腦部影像
  • 全球放射性熱成像市場：釔-90 細分市場（依放射性同位素）、實際及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 釔-90微球用於治療肝癌
  • 釔-90用於放射免疫治療
  • 全球放射性熱療市場：鎦(Lu) 177 細分市場（依放射性同位素分類），2019-2024 年、2024-2029 年、2034 年實際及預測
  • 鎦 - 177 PSMA 用於治療前列腺癌
  • 鎦-177 Dotatate 用於神經內分泌腫瘤
  • 全球放射性熱療市場：按銅 (Cu)-67（按放射性同位素）細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 銅-67用於標靶放射線治療
  • 銅-67 臨床試驗
  • 全球放射熱成像市場：按銅（Cu）-64（按放射性同位素）細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 用於PET成像的銅-64
  • 銅64用於放射治療
  • 全球放射性熱療市場：細分：其他放射性同位素（按放射性同位素），實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 鐳 223，釤 153
  • 治療診斷學中的其他新興放射性同位素

第7章 區域和國家分析

  • 全球放射熱療市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球放射熱療市場：按國家、實際結果和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 放射治療市場：競爭格局
  • 放射治療市場：公司簡介
    • Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • GE Healthcare Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Siemens Healthineers
  • Orano Med
  • Curium SAS
  • IBA Molecular
  • The Eckert & Ziegler Group
  • Advanced Accelerator Applications（AAA）
  • Telix Pharmaceuticals Limited.
  • Abdera Therapeutics
  • Blue Earth Diagnostics
  • Sirtex Medical Limited
  • Y-mAbs Therapeutics Inc.
  • ITM Radiopharma
  • NorthStar Medical Radioisotopes LLC
  • Trasis SA
  • Molecular Targeting Technologies Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年放射治療市場：提供新機會的國家
  • 2029 年放射治療市場：細分領域帶來新機會
  • 2029年放射熱成像市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r25249u

Radiotheranostics refers to a medical approach that combines diagnoses and treatments using imaging methods with radioactive substances to precisely identify specific targets within the body. This method is employed for delivering targeted radiation therapy to defined locations, enabling precise and tailored cancer treatment while minimizing damage to healthy tissues. This approach enhances treatment outcomes and improves patient care.

The primary radiotheranostics radioisotopes include technetium-99, gallium-68, iodine-131, iodine-123, fludeoxyglucose-18F, yttrium-90, lutetium (Lu) 177, copper (Cu) 67, copper (Cu) 64, and others. Technetium (Tc) is a silver-gray radioactive metal that occurs naturally at extremely low levels in the earth's crust but is predominantly man-made. It is used for skeletal and heart muscle scans and imaging of various organs such as the brain, thyroid, lungs, liver, spleen, kidneys, gall bladder, bone marrow, salivary and lacrimal glands, as well as in some specialized medical research. The different approaches include targeted therapeutic and targeted diagnostic applications in both oncology and non-oncology. The end users of this technology include hospitals and clinics, pharmaceutical and biotechnology companies, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The radio theranostics market research report is one of a series of new reports from The Business Research Company that provides radio theranostics market statistics, including radio theranostics industry global market size, regional shares, competitors with a radio theranostics market share, detailed radio theranostics market segments, market trends, and opportunities, and any further data you may need to thrive in the radio theranostics industry. This radio theranostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The radiotheranostics market size has grown rapidly in recent years. It will grow from $8.79 billion in 2024 to $10.05 billion in 2025 at a compound annual growth rate (CAGR) of 14.4%. The growth in the historic period can be attributed to advancements in nuclear medicine, a rise in cancer cases, personalized medicine development, advances in radiopharmaceuticals, regulatory approvals and standards.

The radiotheranostics market size is expected to see rapid growth in the next few years. It will grow to $16.87 billion in 2029 at a compound annual growth rate (CAGR) of 13.8%. The growth in the forecast period can be attributed to advancements in targeted cancer therapies, expansion in oncology research, rise in chronic diseases, and growth in theranostic applications. Major trends in the forecast period include theranostic radiopharmaceutical development, expanding applications beyond oncology, personalized radiopharmaceuticals, nanotechnology in radiotheranostics, regulatory shifts and standardization.

The forecast of 13.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. supply chains by increasing costs for luorodeoxyglucose-Positron Emission Tomography -Positron Emission Tomography radiotracers and theranostic probes imported from the Netherlands and South Korea, potentially limiting targeted oncology therapies and raising diagnostic imaging burdens. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of cancer is anticipated to drive the growth of the radiotheranostics market in the future. Cancer is characterized by the uncontrolled development of certain cells in the body that spread to other areas. Radiotheranostics medications are widely used in oncology to provide the concept of personalized medicine through paired diagnostic and therapeutic radionuclide probes. These probes enable selective and targeted detection and treatment of specific (typically cancerous) cells, tailored to the patient's specific condition to enhance treatment efficacy and improve clinical outcomes. For example, in January 2024, the American Cancer Society, a US-based nonprofit organization focused on cancer advocacy, reported an increase in cancer cases to 2,001,140, up from 1,958,310 in 2023, marking a growth of 2.19%. Thus, the increasing prevalence of cancer is propelling the radiotheranostics market.

The increasing adoption of personalized medicine is poised to contribute to the growth of the radiotheranostics market. Personalized medicine, an innovative healthcare approach tailoring medical treatments to individual patient characteristics, is facilitated by radiotheranostics. This approach, utilizing specific radiopharmaceuticals, enables the identification of individualized molecular targets, allowing for precise diagnosis and tailored therapeutic interventions based on the patient's unique characteristics. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% classified as personalized medicines, according to the Personalized Medicine Coalition. The increasing adoption of personalized medicine is a key driver for the growth of the radiotheranostics market.

An emerging trend in the radiotheranostics market is the focus on product innovations. Major companies are directing their efforts towards creating innovative products to solidify their market positions. For instance, Advanced Cyclotron Systems Inc., a Canada-based company specializing in cyclotrons for medical isotope production, introduced TR-ALPHA in May 2023. This innovation is designed for the production of alpha-emitting radioisotopes used in cancer treatment. TR-ALPHA addresses market demands for a low-cost cyclotron capable of producing substantial amounts of Astatine-211, a promising alpha-emitting radioisotope. This product is smaller, more cost-effective, and easier to operate compared to previous cyclotron models, making it an ideal solution for efficiently producing therapeutic alpha-emitting radioisotopes.

Major companies in the radiotheranostics market are forming strategic partnerships to develop new products and strengthen their market positions. Collaborations and partnerships in this market facilitate the pooling of resources, expertise, and research efforts, accelerating the development, commercialization, and widespread adoption of advanced diagnostic and therapeutic solutions. In April 2022, Ion Beam Applications partnered with SCK CEN to advance the production of the radioisotope Actinium-225, a crucial element in cancer treatment. This collaboration aims to establish a state-of-the-art production facility in Mol, Belgium, combining expertise in particle accelerators and the provision of rare raw materials. Such collaborations are crucial for making radiotheranostic solutions commercially viable for treating various cancers with enhanced precision.

In June 2023, Ariceum Therapeutics GmbH, a Germany-based radiopharmaceutical company, acquired Theragnostics Ltd. for $41.5 million. This strategic acquisition is intended to broaden Ariceum's portfolio of therapeutic and diagnostic assets in late preclinical and early clinical development and expand its operations in the US. Theragnostics Ltd., a US-based radiopharmaceutical company, specializes in offering radio-theranostic solutions.

Major companies operating in the radiotheranostics market include Lantheus Holdings Inc., Cardinal Health Inc., GE Healthcare Inc., Bayer AG, Novartis AG, Siemens Healthineers, Orano Med, Curium SAS, IBA Molecular, The Eckert & Ziegler Group, Advanced Accelerator Applications (AAA), Telix Pharmaceuticals Limited., Abdera Therapeutics, Blue Earth Diagnostics, Sirtex Medical Limited, Y-mAbs Therapeutics Inc., ITM Radiopharma, NorthStar Medical Radioisotopes LLC, Trasis S.A., Molecular Targeting Technologies Inc., RadioMedix Inc, Clarity Pharmaceuticals, Actinium Pharmaceuticals Inc., Navidea Biopharmaceuticals Inc.

North America was the largest region in the radiotheranostics market in 2024. The regions covered in the radiotheranostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the radiotheranostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The radiotheranostics market consists of sales of iodine-125, radium-223 (223Ra), astatin-211 (211At), actinium-225 (225Ac), lead-212 (212Pb), bismuth-212 (212Bi), thorium-227, strontium-89 (89Sr), rhenium-188 (188Re), and samarium-153 (153Sm). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Radiotheranostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on radiotheranostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for radiotheranostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The radiotheranostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Radioisotope: Technetium-99; Gallium-68; Iodine-131; Iodine-123; Fludeoxyglucose-18F; Yttrium-90; Lutetium (Lu) 177; Copper (Cu) 67; Copper (Cu) 64; Other Radioisotopes
  • 2) By Approach: Targeted Therapeutic; Targeted Diagnostic
  • 3) By Application: Oncology; Non-Oncology
  • 4) By End-Users: Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End-Users
  • Subsegments:
  • 1) By Technetium-99: Technetium-99m; Technetium-99 Pertechnetate
  • 2) By Gallium-68: Gallium-68 DOTATATE; Gallium-68 PSMA
  • 3) By Iodine-131: Iodine-131 For Thyroid Cancer Treatment; Iodine-131 For Hyperthyroidism Treatment
  • 4) By Iodine-123: Iodine-123 For Thyroid Scans; Iodine-123 For Cardiac Imaging
  • 5) By Fludeoxyglucose-18F (FDG): FDG For Oncology Imaging; FDG For Brain Imaging
  • 6) By Yttrium-90: Yttrium-90 Microspheres For Liver Cancer; Yttrium-90 For Radioimmunotherapy
  • 7) By Lutetium (Lu) 177: Lutetium-177 PSMA For Prostate Cancer; Lutetium-177 DOTATATE For Neuroendocrine Tumors
  • 8) By Copper (Cu) 67: Copper-67 For Targeted Radiotherapy; Copper-67 In Clinical Trials
  • 9) By Copper (Cu) 64: Copper-64 For PET Imaging; Copper-64 For Radiotherapy
  • 10) By Other Radioisotopes: Radium-223; Samarium-153; Other Emerging Radioisotopes In Theranostics
  • Companies Mentioned: Lantheus Holdings Inc.; Cardinal Health Inc.; GE Healthcare Inc.; Bayer AG; Novartis AG; Siemens Healthineers; Orano Med; Curium SAS; IBA Molecular; The Eckert & Ziegler Group; Advanced Accelerator Applications (AAA); Telix Pharmaceuticals Limited.; Abdera Therapeutics; Blue Earth Diagnostics; Sirtex Medical Limited; Y-mAbs Therapeutics Inc.; ITM Radiopharma; NorthStar Medical Radioisotopes LLC; Trasis S.A.; Molecular Targeting Technologies Inc.; RadioMedix Inc; Clarity Pharmaceuticals; Actinium Pharmaceuticals Inc.; Navidea Biopharmaceuticals Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Radiotheranostics Market Characteristics

3. Radiotheranostics Market Trends And Strategies

4. Radiotheranostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Radiotheranostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Radiotheranostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Radiotheranostics Market Growth Rate Analysis
  • 5.4. Global Radiotheranostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Radiotheranostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Radiotheranostics Total Addressable Market (TAM)

6. Radiotheranostics Market Segmentation

  • 6.1. Global Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Technetium-99
  • Gallium-68
  • Iodine-131
  • Iodine-123
  • Fludeoxyglucose-18F
  • Yttrium-90
  • Lutetium (Lu) 177
  • Copper (Cu) 67
  • Copper (Cu) 64
  • Other Radioisotopes
  • 6.2. Global Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Targeted Therapeutic
  • Targeted Diagnostic
  • 6.3. Global Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Non-Oncology
  • 6.4. Global Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Pharmaceutical And Biotechnology Companies
  • Other End-Users
  • 6.5. Global Radiotheranostics Market, Sub-Segmentation Of Technetium-99, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Technetium-99m
  • Technetium-99 Pertechnetate
  • 6.6. Global Radiotheranostics Market, Sub-Segmentation Of Gallium-68, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gallium-68 DOTATATE
  • Gallium-68 PSMA
  • 6.7. Global Radiotheranostics Market, Sub-Segmentation Of Iodine-131, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Iodine-131 For Thyroid Cancer Treatment
  • Iodine-131 For Hyperthyroidism Treatment
  • 6.8. Global Radiotheranostics Market, Sub-Segmentation Of Iodine-123, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Iodine-123 For Thyroid Scans
  • Iodine-123 For Cardiac Imaging
  • 6.9. Global Radiotheranostics Market, Sub-Segmentation Of Fludeoxyglucose-18F (FDG), By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • FDG For Oncology Imaging
  • FDG For Brain Imaging
  • 6.10. Global Radiotheranostics Market, Sub-Segmentation Of Yttrium-90, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Yttrium-90 Microspheres For Liver Cancer
  • Yttrium-90 For Radioimmunotherapy
  • 6.11. Global Radiotheranostics Market, Sub-Segmentation Of Lutetium (Lu) 177, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lutetium-177 PSMA For Prostate Cancer
  • Lutetium-177 DOTATATE For Neuroendocrine Tumors
  • 6.12. Global Radiotheranostics Market, Sub-Segmentation Of Copper (Cu) 67, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Copper-67 For Targeted Radiotherapy
  • Copper-67 In Clinical Trials
  • 6.13. Global Radiotheranostics Market, Sub-Segmentation Of Copper (Cu) 64, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Copper-64 For PET Imaging
  • Copper-64 For Radiotherapy
  • 6.14. Global Radiotheranostics Market, Sub-Segmentation Of Other Radioisotopes, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radium-223; Samarium-153
  • Other Emerging Radioisotopes In Theranostics

7. Radiotheranostics Market Regional And Country Analysis

  • 7.1. Global Radiotheranostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Radiotheranostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Radiotheranostics Market

  • 8.1. Asia-Pacific Radiotheranostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Radiotheranostics Market

  • 9.1. China Radiotheranostics Market Overview
  • 9.2. China Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Radiotheranostics Market

  • 10.1. India Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Radiotheranostics Market

  • 11.1. Japan Radiotheranostics Market Overview
  • 11.2. Japan Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Radiotheranostics Market

  • 12.1. Australia Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Radiotheranostics Market

  • 13.1. Indonesia Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Radiotheranostics Market

  • 14.1. South Korea Radiotheranostics Market Overview
  • 14.2. South Korea Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Radiotheranostics Market

  • 15.1. Western Europe Radiotheranostics Market Overview
  • 15.2. Western Europe Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Radiotheranostics Market

  • 16.1. UK Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Radiotheranostics Market

  • 17.1. Germany Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Radiotheranostics Market

  • 18.1. France Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Radiotheranostics Market

  • 19.1. Italy Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Radiotheranostics Market

  • 20.1. Spain Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Radiotheranostics Market

  • 21.1. Eastern Europe Radiotheranostics Market Overview
  • 21.2. Eastern Europe Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Radiotheranostics Market

  • 22.1. Russia Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Radiotheranostics Market

  • 23.1. North America Radiotheranostics Market Overview
  • 23.2. North America Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Radiotheranostics Market

  • 24.1. USA Radiotheranostics Market Overview
  • 24.2. USA Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Radiotheranostics Market

  • 25.1. Canada Radiotheranostics Market Overview
  • 25.2. Canada Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Radiotheranostics Market

  • 26.1. South America Radiotheranostics Market Overview
  • 26.2. South America Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Radiotheranostics Market

  • 27.1. Brazil Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Radiotheranostics Market

  • 28.1. Middle East Radiotheranostics Market Overview
  • 28.2. Middle East Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Radiotheranostics Market

  • 29.1. Africa Radiotheranostics Market Overview
  • 29.2. Africa Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Radiotheranostics Market Competitive Landscape And Company Profiles

  • 30.1. Radiotheranostics Market Competitive Landscape
  • 30.2. Radiotheranostics Market Company Profiles
    • 30.2.1. Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. GE Healthcare Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Radiotheranostics Market Other Major And Innovative Companies

  • 31.1. Siemens Healthineers
  • 31.2. Orano Med
  • 31.3. Curium SAS
  • 31.4. IBA Molecular
  • 31.5. The Eckert & Ziegler Group
  • 31.6. Advanced Accelerator Applications (AAA)
  • 31.7. Telix Pharmaceuticals Limited.
  • 31.8. Abdera Therapeutics
  • 31.9. Blue Earth Diagnostics
  • 31.10. Sirtex Medical Limited
  • 31.11. Y-mAbs Therapeutics Inc.
  • 31.12. ITM Radiopharma
  • 31.13. NorthStar Medical Radioisotopes LLC
  • 31.14. Trasis S.A.
  • 31.15. Molecular Targeting Technologies Inc.

32. Global Radiotheranostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Radiotheranostics Market

34. Recent Developments In The Radiotheranostics Market

35. Radiotheranostics Market High Potential Countries, Segments and Strategies

  • 35.1 Radiotheranostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Radiotheranostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Radiotheranostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer